Biotech Act
Europe must rethink how it values medicines, says EFPIA chief [Advocacy Lab]
Europe is becoming less attractive for pharmaceutical innovation after two decades of declining R&D investment, says pharma industry leader
![Europe must rethink how it values medicines, says EFPIA chief [Advocacy Lab]](https://www.rivonews.online/wp-content/uploads/2026/05/NathalieMoll-EuractivConf-1183x788-1-800x480.jpeg)